Istituti Clinici Scientifici Maugeri SpA SB, IRCCS, Institute of Bari, Bari, Italy.
Regional General Hospital "F. Miulli", Acquaviva delle Fonti, Bari, Italy.
Int J Cardiol. 2025 Jan 1;418:132605. doi: 10.1016/j.ijcard.2024.132605. Epub 2024 Oct 1.
The effects of cardiac rehabilitation (CR) in old patients with heart failure (HF) and severe functional impairment (SFI) are not well established.
We studied 1397 patients with HF and severe functional impairment, defined as a six-minute walking distance (6MWD) <300 m, admitted to inpatient CR. The patients were divided into three groups: Group A (young, ≤65 years), Group B (old-young, 66 to 75 years), and Group C (old-old, >75 years). The primary outcome was an increase in 6MWD to 300 m or more after CR. We used multivariable Cox modeling to determine the association of the primary outcome with three-year mortality after discharge from CR.
At admission to CR, 38.5 % of the patients in group A, 40.0 % in group B, and 46.3 % in group C (p = .029) were unable to walk unassisted. Of these patients, 29.5 %, 32.6 %, and 30.2 % (p = .835), respectively, regained the ability to walk independently. Overall, 370 (26.5 %) patients achieved the primary outcome, 49.1 % in group A, 32.2 % in group B, and 15.7 % in group C (p < .001). The adjusted HR of 3-year mortality for the patients who achieved the primary outcome was 0.53 (95 %CI 0.34-0.83; p = .005) in group A, 0.49 (95 %CI 0.33-0.74; p = .001) in group B, and 0.68 (95 %CI 0.47-0.98; p = .037) in group C.
Our findings suggest that old-old patients with HF and severe functional impairment may benefit from CR and that functional improvement may predict improved survival.
心脏康复(CR)对老年心力衰竭(HF)和严重功能障碍(SFI)患者的影响尚未得到充分证实。
我们研究了 1397 名 HF 和严重功能障碍患者,这些患者的六分钟步行距离(6MWD)<300m,被收入住院 CR。患者被分为三组:A 组(年轻,≤65 岁)、B 组(老-年轻,66 至 75 岁)和 C 组(老-老,>75 岁)。主要结局是 CR 后 6MWD 增加到 300m 或更多。我们使用多变量 Cox 模型来确定主要结局与 CR 出院后三年死亡率之间的关联。
在 CR 入院时,A 组、B 组和 C 组分别有 38.5%、40.0%和 46.3%(p=0.029)的患者无法独立行走。在这些患者中,分别有 29.5%、32.6%和 30.2%(p=0.835)恢复了独立行走的能力。总体而言,370 名(26.5%)患者达到了主要结局,A 组为 49.1%,B 组为 32.2%,C 组为 15.7%(p<0.001)。达到主要结局的患者三年死亡率的调整 HR 为 A 组 0.53(95%CI 0.34-0.83;p=0.005)、B 组 0.49(95%CI 0.33-0.74;p=0.001)和 C 组 0.68(95%CI 0.47-0.98;p=0.037)。
我们的发现表明,HF 和严重功能障碍的老-老年患者可能受益于 CR,功能改善可能预示着生存率的提高。